Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tokuyama ( (JP:4043) ) has shared an update.
Tokuyama reported that while the consolidation of the Tokuyama Life Science Group and solid demand for semiconductor-related products supported revenue, overall net sales declined year on year due to worsening overseas market conditions for vinyl chloride-related products. Operating profit increased compared with the previous year, driven by firm semiconductor-related sales and manufacturing cost improvements, but based on results through the third quarter of fiscal 2025, the company revised its full-year performance forecast downward, signaling a more cautious earnings outlook for stakeholders.
The most recent analyst rating on (JP:4043) stock is a Buy with a Yen4989.00 price target. To see the full list of analyst forecasts on Tokuyama stock, see the JP:4043 Stock Forecast page.
More about Tokuyama
Tokuyama Corporation operates in the chemical and life sciences industries, producing materials such as semiconductor-related products and vinyl chloride, and has expanded into in vitro diagnostics and related pharmaceutical materials through the consolidation of the Tokuyama Life Science (TLS) Group.
Average Trading Volume: 389,011
Technical Sentiment Signal: Buy
Current Market Cap: Yen324.4B
See more insights into 4043 stock on TipRanks’ Stock Analysis page.